Form D · Biotechnology
FIRSTSTRING RESEARCH INC
Charleston, SC · CIK 0001366682
Offering snapshot reported Apr 15, 2010 · SEC filing
- Reported sold
- $3.24M Offering amount: $5M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 30, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 15, 2010 | Initial | $3,237,500 | No comparison | 18 | SEC filing |
| Jul 31, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 17, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 9, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-140627
Source: Form D, filed Apr 15, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Grant Carwile | Director |
| Gautam Ghatnekar | Director, Executive |
| James Mcnab, Jr. | Director |
| Curtis Mo | Executive |
| Ned Payne | Director |
| Stephen Speer | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
475 A East Bay Street
Charleston, SC, 29403
Charleston, SC, 29403